By: Christopher Parrella, Esq., CPC, CHC, CPCO
Parrella Health Law, Boston, MA.
A Health Care Provider Defense and Compliance Firm.

A recent federal court decision out of Tennessee should serve as a reminder to hospitals and health systems across the country that referral relationships remain one of the most heavily scrutinized areas in healthcare enforcement. A federal judge has ruled that Erlanger Health System must face a $28 million False Claims Act lawsuit alleging that the system paid excessive compensation and other financial incentives to physicians in exchange for Medicare referrals.

The decision does not determine liability. But it does something equally important. It allows the government’s case to proceed to discovery which is often where healthcare fraud cases become extremely dangerous for providers. The lawsuit began in 2021 when Erlanger’s former Chief Compliance Officer and former Chief Financial Officer filed a whistleblower complaint alleging that the health system violated the Stark Law by overcompensating physicians to secure Medicare referrals. The complaint alleges that once those referrals were generated, Erlanger billed Medicare for the services provided to those patients creating False Claims Act exposure.

The Department of Justice later intervened in the case and expanded the allegations claiming the health system engaged in a broader compensation scheme involving multiple physicians and leadership roles including medical director and academic positions where compensation allegedly exceeded fair market value or where work was not actually performed.

This ruling highlights an important and often misunderstood aspect of healthcare fraud litigation. Many providers assume that if the government cannot list hundreds or thousands of specific false claims in the complaint, the case will be dismissed. Courts repeatedly reject that argument when a broader scheme is alleged. Once a case reaches discovery, the stakes increase dramatically. Internal emails, compensation analyses, board presentations, compliance reports and communications with physicians all become discoverable. Those documents often become the backbone of enforcement actions settlements and corporate integrity agreements.

The fact that this case was brought by two former senior executives also underscores another critical risk area for healthcare organizations. Compliance leaders, finance officers, coders and billing professionals are among the most frequent whistleblowers in healthcare fraud cases. When those individuals believe compensation arrangements cross legal lines, they often have access to the documentation needed to support their claims.

Here is the call to action. Healthcare systems and providers alike should take this decision as an opportunity to re-examine their physician compensation structures. Ensure that medical director agreements, academic appointments, consulting arrangements and service line leadership roles are supported by fair market value analyses and commercial reasonableness evaluations. Document actual services performed and maintain contemporaneous time records when required. And make sure compliance and legal teams are involved before compensation models are implemented rather than after problems surface.

The Stark Law and the False Claims Act remain two of the most powerful enforcement tools in healthcare and courts continue to allow these cases to move forward when the government can show even a handful of representative claims tied to an alleged referral scheme. If you have any questions or comments about the subject of this blog or want assistance reviewing physician compensation arrangements for Stark and FCA exposure, please contact Parrella Health Law at 857.328.0382 or Chris directly at cparrellahealthlaw.com.